Found 14 matching trials
Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe PHASE1 This study was to compare the rate and extent of absorption of a single dos...
Show More Location
Galderma Investigational Site 7024
Learn More & Join Trial
Nemolizumab for LS PHASE2 Patients ≥ 18 years of age with Lichen sclerosis (LS)...
Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable PHASE3 The primary objective of this study is to investigate the efficacy of nemol...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD) PHASE2 The purpose of this study was to evaluate the pharmacokinetics and safety o...
Show More Location
Galderma Investigational Site
Learn More & Join Trial
Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) PHASE2 The primary objective of this study is to assess the PK/PD relationship of ...
Show More Status
Active Not Recruiting
Location
Galderma Investigational Site (site# 8893)
Learn More & Join Trial
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) PHASE3 The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Show More Location
Galderma Investigational Site
Learn More & Join Trial
A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis PHASE3 The main objective of this study is to assess the long-term durability of r...
Show More Location
Galderma Investigational Site 8521
Learn More & Join Trial
A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) PHASE3 The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Show More Location
Galderma Investigational Site
Learn More & Join Trial
A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab PHASE2 The purpose of this study is to assess the effect of nemolizumab (CD14152) ...
Show More Location
Galderma Investigational Site (Site#9922)
Learn More & Join Trial
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis PHASE3 This is a bridging study only for Chinese subjects. The goal of this clinic...
Show More Location
Multiple Locations
Learn More & Join Trial